Micro robots could print tissue inside the body

Scientists in China have created a micro robot which they say could enable 3D bioprinting inside the body.

One in eight people suffer from stomach ulcers around the world. Now, scientists believe they may have achieved a breakthrough with a 3D bioprinting process which deposits cells right inside the body.[1]

Longevity.Technology: In vivo bioprinting is a process with enormous potential. Stomach ulcers can be extremely painful and debilitating and are much more likely to occur in older people and have a serious impact on extended quality of life. Left untreated, ulcers can result in internal bleeding, leading to anaemia, and, in severe cases, requires hospitalisation and a blood transfusion.

Bioprinting has been attracting increasing attention around the world, with pioneering companies taking technologies from the lab towards commercialisation. It works in much the same way as conventional 3D printing. While that deposits layers of material to create a 3D structure from scratch, bioprinting extrudes living cells to deliver tissues and organs.

In this latest research, scientists in China are developing a miniature bioprinting robot that can easily be introduced into the human body. Researchers were able to use existing techniques using dextrous robots such as mechanical bees and cockroach-inspired robots to produce a microrobot just 30 millimetres in length. When introduced into the body, it unfolds to 59 millimetres and starts bioprinting.

The microrobot was fitted onto an endoscope which was snaked through a curved pipe into a plastic model of a stomach. Once there, they used the device to print gels packed with human stomach lining and muscle cells, which were grown in a laboratory.

According to the results of the study the cells remained viable over the course of 10 days.

The technology holds real potential for the future. Researchers will firstly be looking to reduce its size even more. Ultimately, they believe it could reduce to 12 millimetres, further improving the safety and efficacy of the procedure.

 


 

“… the impact on the millions of people awaiting organ transplant around the world could be profound.”

 


 

In the short term they believe the technology will be useful to repair wounds and to augment existing surgical procedures. However, in the longer term, the possibilities are extremely exciting.

The ultimate goal of bioprinting technology is to bioprint living organs that can be used for transplant. If scientists achieve it, the impact on the millions of people awaiting organ transplant around the world could be profound.

Around 6,000 people are currently on the transplant waiting list in the UK [2]. For them, the agonising wait to find a compatible donor, is a matter of life and death. The idea of bio printed organs which can be created and made ready in very little time is transformative. However, even the idea of printing organs outside the body for transplant has issues.

These micro robots raise the possibility in vivo bioprinting and a host of further applications which could improve not only the longevity of life, but also the quality of that life.

[1] https://bit.ly/33WeU1d
[2] https://bit.ly/2HtylHf

Image by PublicDomainPictures from Pixabay
Carla Heyworth
Carla is sub editor at Longevity.Technology and she's the glue that keeps the team on track and the articles rolling-out. She has an extensive background in B2B communications, events and marketing. Carla's a visual person and can often be found behind a camera or editing photos

Latest articles

Epigenetic regulation of protein homeostasis following DNA damage

Recent study identifies critical regulator of protein biosynthesis recovery and homeostasis required for Longevity. Unresolved DNA damage caused by intrinsic and environmental factors accumulates during...

Deep Longevity and Longenesis collaborate to clock aging

Start the clock to stop the clock – centralised data will aid Longevity research.  Deep Longevity, which engages in the development of explainable AI systems...

Big Brother approach to accelerate preclinical studies

Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies. A Danish start-up aims...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...